MED13L and cardiac anomalies - developmental delay - facial dysmorphism syndrome: Our findings support the conclusion that the phenotype of patients with loss-of-function variants in the MED13L gene could be a clinically recognizable MRFACD syndrome, especially when ID is accompanied by development and speech delay and specific dysmorphic features.